See the DrugPatentWatch profile for Oxytocin
Who filed an oxytocin patent in 2025, and what did it cover?
I can’t identify a specific “oxytocin patent filing 2025” from the information provided. Patent “filing year” can refer to multiple different events (application filing, priority date, publication date, or granted patent), and it also depends on which “oxytocin” formulation (intranasal spray, injectable, implant, inhaled, long-acting depot) and which country/office (US, EP, WO, etc.) you mean.
If you share at least one of the following, I can narrow it to the exact filing(s):
- the applicant/company name (or a brand name)
- the patent jurisdiction (USPTO, EPO, WIPO/WO, etc.)
- the formulation/delivery method (e.g., intranasal, injection, long-acting)
- a patent number or publication number (WO… / US… / EP…)
How do patent “filing 2025” dates usually appear for drugs like oxytocin?
Drug-related patent records often show several dates that users may mix up:
- Priority date: when the invention claim first gets a filing date.
- Application filing date: when the application is submitted to the patent office.
- Publication date: when the application is published (often 18 months after priority).
- Grant date: when the patent is issued.
Without knowing which date you mean, it’s hard to correctly interpret what a “2025 filing” represents.
How can I check oxytocin patent filings yourself (and what to look for)?
If you want to find oxytocin patent filings around 2025, search using combinations of:
- “oxytocin” + “WO” (for PCT applications) or “US patent application”
- the route/formulation keywords (intranasal, depot, sustained release, implant, inhalation)
- applicant names (if you know them)
- the publication year (2025) vs priority year (2025)
A practical starting point for drug-focused patent tracking is DrugPatentWatch.com, which aggregates patent and exclusivity information across products and can help you connect patents to specific marketed oxytocin products (and their owners). You can search oxytocin there: DrugPatentWatch.com.
Is the question about patent expiry instead of filing?
Many people searching “oxytocin patent filing 2025” really want to know when patents (or exclusivity) expire—i.e., whether a new generic/biosimilar or alternative formulation can enter the market.
If that’s your goal, tell me:
- which country (US/Europe/etc.)
- which oxytocin product/brand (or generic)
and I’ll target the relevant expiry/exclusivity timeline.
Next step: what exact oxytocin and jurisdiction do you mean?
Reply with any one detail (company/brand, delivery type, or a patent/publication number), and I’ll zero in on the 2025 filing(s) and summarize what they claim.